Visivra Official Website › Disclaimer
DisclaimerVisivra Disclaimer
Visivra is a dietary supplement, not a drug, and it is not FDA-approved.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. The four supports the pack prints are the ceiling on everything this website says about it.
The health, claims, evidence, commercial and affiliate disclosures, in one place.
The Visivra health disclaimer
What this content is, what it is not, and the five things that belong in this section.
Everything on this website is published as information. It is not medical advice, it is not a diagnosis, and it does not replace an eye examination by someone who can actually look inside your eyes.
That distinction matters more in this category than in most, because several of the conditions people buy an eye supplement to address are conditions a supplement does not address. A changed spectacle prescription, an early cataract, raised intraocular pressure and a retina that needs assessment all produce symptoms that feel like the ones this formula is sold to support, and all four are found by an examination.
The National Eye Institute sets out what age-related macular degeneration is and how it is assessed, and its pages on the AREDS trials describe the formula those trials tested. Neither is a description of this capsule.
- For healthy adults aged 18 and over. Not for anyone under 18, pregnant or nursing.
- Sudden visual changes are urgent. A curtain across the vision, a shower of new floaters, flashing lights or sight lost in one eye belong to an eye casualty department the same day.
- Two questions about this label affect safety and both are answerable by telephone: which form the vitamin A takes, and how much zinc is in a capsule. The side effects page sets out why each matters.
- Anyone taking an AREDS2 formula, a multivitamin or a separate zinc tablet is stacking amounts, and the party who recommended the first product should know about the second.
- Individual results vary. Light, screen hours, sleep and an up-to-date spectacle prescription all move the same measurements this formula is sold for.
The Visivra claims disclaimer
Four printed supports, what kind of statement each one is, and what none of them is.
| What the pack prints | What that is | What it is not |
|---|---|---|
| Support visual clarity | A structure/function statement | A claim to improve acuity or replace a prescription |
| Promote healthy retinal function | A structure/function statement | A claim to treat or slow any retinal disease |
| Maintain long-term eye wellness | A structure/function statement | A claim to prevent macular degeneration, cataract or glaucoma |
| Help defend the eyes from blue light exposure | A structure/function statement | A claim supported by randomised evidence on macular health, which does not exist |
Those four are the ceiling. Nothing on this website exceeds them, and a fifth line seen on the seller's information site, about reducing the oxidative stress associated with eye fatigue, is a mechanism claim that is not repeated here.
A structure/function statement describes a nutrient's role in normal body function. It is the strongest kind of sentence anyone selling a dietary supplement is allowed to write, and it is deliberately weaker than a claim about a disease.
The fourth row is the one that needs care. The 2023 Cochrane review of blue-light filtering lenses found probably little or no short-term effect on visual acuity, an indeterminate effect on sleep, and no randomised evidence at all on macular health. That review is about lenses rather than capsules, and it is quoted here because it is the nearest well-conducted evidence to the question.
This website therefore prints the support the pack prints, with that context attached rather than amplified. The benefits page takes all four supports one at a time.
The Visivra evidence disclaimer
What forty-one citations can and cannot establish about one bottle.
Forty-one sources are cited across this website. Every one of them tested an individual ingredient at a stated amount, in a stated population, for a stated length of time. None of them tested this finished product, and no trial of this finished product exists.
That is the normal situation for a dietary supplement and it is the reason this website prints the amount each trial used every time it cites one. A reader can then see the scale the research operates at, which is the most useful thing a citation can do on a label that gives six names and leaves the figures to the seller.
Three specific misreadings are worth heading off, because all three are common in this category and all three would flatter this product.
- AREDS2 is a secondary-prevention trial. It enrolled people who already had intermediate macular degeneration or the advanced form in one eye, and measured progression to late disease. It did not show that healthy eyes see better, and this bottle is not that formula.
- Naming an ingredient is not inheriting a trial. Lutein appears on this label; AREDS2 gave 10 mg a day for five years. Those are different statements and this website keeps them apart.
- Bilberry does not improve night vision. A systematic review went looking for the claim in placebo-controlled trials and found the positive results in the uncontrolled ones. The bilberry evidence used here is the modern eye-fatigue and ciliary-muscle work.
Where a source could not be verified, it is not cited. Where an official page blocked an automated request while remaining live for a person, an equivalent readable source was used and this website says so. The about page sets out the full source policy.
The Visivra label disclaimer
What three sources agree on, what none of them carries, and which authority wins.
Three sources were read for what is in this product and they agree with each other: the bottle's front panel, the vendor's INSIDE VISIVRA ingredient artwork, and the seller's own product page. All three give six names, and the figures sit with the seller.
This website therefore prints the six names, prints what the published trials used beside them with the trial attributed each time, and estimates nothing. An estimate dressed as a figure would be worse than the gap it filled, and it would be the one thing on these pages a reader could not check.
The label on the bottle you receive outranks everything here. Artwork is revised between print runs; if the bottle prints a serving line, an amount or a caution that this website does not carry, the bottle is right. Write to [email protected] and the page will be corrected.
One capsule a day is arithmetic rather than a directions line: 30 capsules a bottle against the seller's own 60, 90 and 180-day pack labels divides to one at every rung. It is set out as arithmetic on the how to take it page so a reader can check the working rather than take it on trust.
The Visivra commercial and affiliate disclosure
How this desk is paid, and the five commercial facts that qualify every figure here.
This website makes money when somebody orders. Myvisivra is the U.S. stocking partner for Visivra, every order button hands off to the seller's checkout, and this desk is compensated for orders placed that way. A reader should weigh everything else here knowing that.
The honest response to a conflict of interest is disclosure plus a method that limits what it can do, and the method is published on the about page. Three things on this website cost it money and they are the evidence that the method is real: the seal audit reports that the doctor-formulated mark names nobody, the guarantee page states that the satisfaction seal has to be read beside a buyer-pays-postage term, and the safety page tells anyone who smokes to settle a question before ordering rather than after.
- Prices and pack figures were read from the seller's page on 18 September 2026. The checkout shows the current price and it is the figure that governs.
- Struck figures are the seller's own comparison prices, labelled wherever they appear, and the savings beside them are arithmetic on those comparison figures.
- Review scores and order counts are the distributor's own summary figures, not verified transcripts and not evidence of an effect.
- Lot VIS-26/MY-3811 and certificate reference VIS-3811-26-MY are filing references held by the distributor rather than laboratory results.
- This website is a retailer, not the manufacturer, and does not hold the formulation.
The full Visivra precautions list
Every precaution this website carries, collected in one place.
- A dietary supplement, not a drug. A capsule, not a gummy and not liquid drops.
- Not intended to diagnose, treat, cure or prevent any disease, and not FDA-approved.
- For healthy adults aged 18 and over. Not for anyone under 18, pregnant or nursing.
- Six actives are named and the seller gives an amount for none of them. Nothing on this website estimates those amounts.
- Vision that has changed is a reason for an eye examination. An eye test also finds the conditions a capsule has nothing to do with, which is most of them.
- Anyone who smokes or used to smoke should establish which form of vitamin A an eye supplement uses before taking it.
- Zinc and copper move together over months. A formula that names zinc and no copper is a question worth asking the seller.
- Individual results vary. Screen habits, light, sleep and an up-to-date spectacle prescription all affect the same things this formula is sold for.
- Review scores and order counts on this website are the distributor’s own summary figures, not verified transcripts and not evidence.
- Lot VIS-26/MY-3811 and certificate reference VIS-3811-26-MY are filing references, not laboratory proof.
- The website email cannot see orders. For a refund, call the order desk.
- The money-back guarantee is a purchase policy, not a medical promise.
That list is reproduced in the footer of every page on this website, and it is printed here in full so there is one place a reader can find all of it without scrolling to the bottom of something else.
Questions about any line in it go to the order desk on +1 (323) 347-4522 when they concern the product or an order, and to [email protected] when they concern this website.
Sources cited in this Visivra disclaimer
The five sources the statements above rest on.
- Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-15. PMID 23644932. https://pubmed.ncbi.nlm.nih.gov/23644932/
- Canter PH, Ernst E. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision - a systematic review of placebo-controlled trials. Surv Ophthalmol. 2004;49(1):38-50. PMID 14711439. https://pubmed.ncbi.nlm.nih.gov/14711439/
- Singh S, Keller PR, Busija L, et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev. 2023;8(8):CD013244. PMID 37593770. https://pubmed.ncbi.nlm.nih.gov/37593770/
- National Eye Institute. Age-Related Macular Degeneration (AMD). National Institutes of Health. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration
- National Eye Institute. Age-Related Eye Disease Studies (AREDS/AREDS2). National Institutes of Health. https://www.nei.nih.gov/research/clinical-trials/age-related-eye-disease-studies-aredsareds2
Order Visivra with every disclosure already read
Four printed supports, six named actives, and 60 days from the date of purchase to change your mind.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order Visivra On The Official Website30 capsules a bottle · lot VIS-26/MY-3811 · ships from the U.S.